Stockscreener 앱 받기
39.06
5.79%
-2.40
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure (ATRC) Is Down 5.8% After Issuing 2026 Profitability Guidance And Expanding Credit Facility - Yahoo Finance
What are AtriCure Incs recent SEC filings showingMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results - Your Wyoming Link
AtriCure Stock (+11%): Profitability Inflection Ignites Re-Rate - Trefis
AtriCure (NASDAQ:ATRC) Trading 6.7% HigherHere's Why - MarketBeat
AtriCure Inc (ATRC) Shares Up 8.49% on Jan 15 - GuruFocus
AtriCure CEO Touts $10B AFib and Pain Market, Raises EBITDA Outlook at JPMorgan Conference - MarketBeat
ATRC: Innovation and clinical evidence drive growth in AFib and pain management, with strong financial results - TradingView — Track All Markets
Atricure (ATRC) Receives a Buy from Canaccord Genuity - The Globe and Mail
Street Watch: What is AtriCure Incs revenue forecastBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn
AtriCure reports 13% revenue growth in Q4 2025, provides 2026 outlook - Investing.com Nigeria
AtriCure, Inc. (ATRC) Investor Outlook: Analyzing A 40% Potential Upside - DirectorsTalk Interviews
AtriCure (NASDAQ:ATRC) Shares Down 7.6%Time to Sell? - MarketBeat
AtriCure, Inc. and AtriCure, LLC Enter into a First Amendment to Credit Agreement - marketscreener.com
ATRC: Projected Strong Revenue and Growth by 2026 - GuruFocus
AtriCure (NASDAQ:ATRC) Releases Q4 2025 Earnings Guidance - MarketBeat
AtriCure (ATRC) Anticipates Strong Revenue Growth in Q4 2025 - GuruFocus
AtriCure's preliminary Q4 revenue rises 13%, slightly beats estimates - TradingView — Track All Markets
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 - Yahoo Finance
AtriCure Reports Strong Preliminary 2025 Revenue Growth - TipRanks
AtriCure IncEnters first amendment to credit agreementSEC filing - marketscreener.com
AtriCure Signs First Amendment to Credit Agreement With JPMorgan Chase Bank - TradingView — Track All Markets
A Look At AtriCure (ATRC) Valuation As Earnings Beats And Analyst Optimism Lift Confidence - simplywall.st
Jobs Data: Why is AtriCure Inc stock going down2025 Fundamental Recap & Stock Portfolio Risk Management - baoquankhu1.vn
AtriCure, Inc. (ATRC) soars to 52-week high, time to cash out? - MSN
Will AtriCure Inc. stock benefit from green energy trendsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Улправда
(ATRC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
AtriCure, Inc. (ATRC) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Is AtriCure Inc. stock a defensive play in 2025July 2025 Movers & Fast Gaining Stock Strategy Reports - Улправда
Will AtriCure Inc. stock benefit from automationJuly 2025 Short Interest & High Return Trade Guides - Улправда
Will AtriCure Inc. stock continue upward momentumQuarterly Risk Review & AI Powered Trade Plan Recommendations - Улправда
Will AtriCure Inc. stock attract ESG investorsJuly 2025 Breakouts & High Accuracy Trade Alerts - Улправда
AtriCure (NASDAQ:ATRC) Reaches New 12-Month HighWhat's Next? - MarketBeat
AtriCure stock hits 52-week high at $43.18 By Investing.com - Investing.com Canada
AtriCure stock hits 52-week high at $43.18 - Investing.com
Fed Watch: How risky is AtriCure Inc. stock nowJuly 2025 Earnings & Comprehensive Market Scan Insights - Улправда
Is AtriCure Inc. stock trading at a premium valuation2025 Earnings Impact & Community Trade Idea Sharing Platform - Улправда
AtriCure (NASDAQ:ATRC) Upgraded at Zacks Research - MarketBeat
AtriCure (NASDAQ:ATRC) Share Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Nasdaq Index Fund Medical Devices - Kalkine Media
AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriCl - PharmiWeb.com
AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE TechnologiesResearchAndMarkets.com - The AI Journal
About Us - FinancialContent
Liquidity Mapping Around (ATRC) Price Events - Stock Traders Daily
AtriCure (ATRC): Assessing Valuation After First-In-Human PFA/RFA Procedures and Renewed Analyst Optimism - Yahoo Finance
Assessing AtriCure’s Valuation After a 33.4% Rally in 2025 - Yahoo Finance
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Has AtriCure (ATRC) Outpaced Other Medical Stocks This Year? - sharewise.com
AtriCure (NASDAQ:ATRC) Stock Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
AtriCure Inc (NASDAQ:ATRC) Nasdaq Index Medical Device Depth - Kalkine Media
What AtriCure (ATRC)'s First Dual-Energy PFA–RFA Procedures Mean For Shareholders - Sahm
Big Money Moves: Will AtriCure Inc stock benefit from green energy trendsVolume Spike & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Analysts See an Over 26% Upside in AtriCure (ATRC) - Insider Monkey
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Assessing AtriCure (ATRC) Valuation After Milestone First‑in‑Human Results for Its Dual Energy Ablation Platform - Sahm
AtriCure price target raised to $48 from $42 at JPMorgan - MSN
AtriCure announces first patients treated with dual energy platform - MSN
Quarterly Recap: What valuation multiples suggest for AtriCure Inc stock - moha.gov.vn
0.01%
1.19%
자본화:
|
볼륨(24시간):